Ledger.Open graph →
SEC Form D · filed August 27, 2025

Absco Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ALLSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Carlo Giovanni Traverso · BROOKLINE, MADirectorStephen Linderman · BROOKLINE, MAExec · DirectorAvik Som · St. Louis, MODirectorStephen Linderman · BROOKLINE, MAExec · DirectorCarlo Giovanni Traverso · BROOKLINE, MADirectorAvik Som · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗